BI Asset Management Fondsmaeglerselskab A S decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 31.4% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 105,447 shares of the healthcare conglomerate’s stock after selling 48,275 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S’s holdings in UnitedHealth Group were worth $30,789,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently modified their holdings of the company. LFA Lugano Financial Advisors SA bought a new position in UnitedHealth Group during the second quarter worth about $25,000. Bayforest Capital Ltd raised its stake in UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 48 shares during the period. Sagard Holdings Management Inc. bought a new position in shares of UnitedHealth Group in the second quarter valued at about $29,000. Islay Capital Management LLC bought a new position in UnitedHealth Group in the 2nd quarter valued at about $31,000. Finally, Kilter Group LLC acquired a new position in shares of UnitedHealth Group in the second quarter valued at approximately $34,000. 87.86% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several research analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price objective on the stock. in a research report on Wednesday, October 29th. Cantor Fitzgerald restated an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Royal Bank Of Canada increased their target price on UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a report on Wednesday, October 29th. Wells Fargo & Company raised their target price on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a report on Tuesday, October 7th. Finally, TD Cowen boosted their price objective on shares of UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a research report on Thursday, October 30th. Seventeen investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $385.54.
UnitedHealth Group Trading Up 1.5%
NYSE UNH opened at $341.83 on Friday. The company has a market cap of $309.65 billion, a price-to-earnings ratio of 17.84, a price-to-earnings-growth ratio of 2.20 and a beta of 0.43. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The business’s fifty day moving average is $339.84 and its 200 day moving average is $316.91. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $606.36.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The company had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. UnitedHealth Group’s revenue was up 12.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $7.15 earnings per share. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be given a dividend of $2.21 per share. The ex-dividend date is Monday, December 8th. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. UnitedHealth Group’s dividend payout ratio is presently 46.14%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- 3 Small Caps With Big Return Potential
- Synopsys Sees Bullish Shift as Ansys Integration Drives Growth
- What is the Nikkei 225 index?
- The Best Holiday Present You Can Give Yourself? Costco Stock
- The How And Why of Investing in Oil Stocks
- Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
